Eli Lilly

2 sessions, November 13–14

Lilly Canada is the Canadian affiliate of Eli Lilly and Company, one of the world’s largest research-based pharmaceutical companies. Our affiliate was founded in 1938 as a result of a collaboration between Eli Lilly and Company and Banting and Best, which produced the world’s first commercially available insulin.

Our work has broadened, and we now focus on diabetes, cancer, immunology, pain and neurodegeneration. Our products save and improve lives. Pharmaceuticals also save overall healthcare costs by improving health outcomes, reducing the need for surgeries, hospitalization, and extended care, and allowing people to return to work sooner. We unite caring with discovery to create medicines that make life better for people around the world.

To learn more, please visit us at www.lilly.ca

Visit website

Sessions at Dermatology Update — Fall 2026

2 sessions

Friday, November 1311:15 – 11:4530 minOpen Pres.

Obesity and Psoriasis: Two Inflammatory Diseases, One Patient

Chairs

Speakers

Coexisting obesity and psoriasis can worsen each other and complicate treatment. This session covers their shared inflammatory biology, new trial data, and practical tools for managing both conditions in patients.

Learning objectives

Understand the shared inflammatory mechanisms linking obesity and psoriasis.
Apply practical tools for assessing and managing obesity in patients with psoriasis.
Be informed about emerging clinical trial data on the concomitant treatment of obesity and psoriasis.

See it in the program

Saturday, November 1416:00 – 18:302 h 30 minAd BoardBy invitation

Lilly Advisory Board

See it in the program